BCRX vs NVR · rev $374.7M vs P/E 15, rev $4.21B
BioCryst Pharmaceuticals Inc (BCRX) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
BCRX currently screens at market cap $1.83B. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the BCRX and NVR stock pages for the full models.
Not investment advice.